Barry M, Keeling P W, Weir D, Feely J
Department of Pharmacology, Trinity College Medical School, St. James's Hospital, Dublin, Ireland.
Clin Pharmacol Ther. 1990 Mar;47(3):366-70. doi: 10.1038/clpt.1990.41.
The concentration of alpha 1-acid glycoprotein, the major determinant of the plasma protein binding of basic drugs, and the extent of lidocaine protein binding was related to the severity of liver disease in 30 cirrhotic patients. In comparison with matched control subjects, alpha 1-acid glycoprotein concentration (77 +/- 7 versus 37 +/- 3 mg/dl; mean +/- SEM; p less than 0.01) and lidocaine binding (69% +/- 2% versus 35% +/- 2%; p less than 0.01) was markedly reduced. There was a significant negative correlation (r = 0.78; p less than 0.01) between free lidocaine and alpha 1-acid glycoprotein concentration. Furthermore, both were significantly related to the severity of liver disease, as assessed by use of the Child Turcotte classification.
在30例肝硬化患者中,碱性药物血浆蛋白结合的主要决定因素α1-酸性糖蛋白的浓度以及利多卡因的蛋白结合程度与肝病的严重程度相关。与匹配的对照受试者相比,α1-酸性糖蛋白浓度(77±7对37±3mg/dl;均值±标准误;p<0.01)和利多卡因结合率(69%±2%对35%±2%;p<0.01)显著降低。游离利多卡因与α1-酸性糖蛋白浓度之间存在显著负相关(r=0.78;p<0.01)。此外,根据Child Turcotte分类法评估,二者均与肝病的严重程度显著相关。